Mostrar el registro sencillo del ítem
Improve the management of cancer-related cognitive impairment in clinical settings: a European Delphi study
dc.rights.license | open | en_US |
dc.contributor.author | DUIVON, Mylene | |
dc.contributor.author | LANGE, Marie | |
dc.contributor.author | BINARELLI, Giulia | |
dc.contributor.author | LEFEL, Johan | |
dc.contributor.author | HARDY-LEGER, Isabelle | |
dc.contributor.author | KIASUWA-MBENGI, Regine | |
dc.contributor.author | MERIC, Jean-Baptiste | |
hal.structure.identifier | Bordeaux population health [BPH] | |
dc.contributor.author | CHARLES, Cecile | |
dc.contributor.author | JOLY, Florence | |
dc.date.accessioned | 2024-01-11T08:32:53Z | |
dc.date.available | 2024-01-11T08:32:53Z | |
dc.date.issued | 2023-11-07 | |
dc.identifier.issn | 1932-2267 | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/187048 | |
dc.description.abstractEn | PurposeCancer-related cognitive impairment (CRCI) is under-addressed by healthcare professionals owing to a lack of clinical management guidelines. This European Delphi study proposes recommendations to healthcare professionals for the management of CRCI in patients with non-central nervous system (non-CNS) cancers.MethodsTwenty-two recommendations were developed based on a literature review and authors' clinical experience, split into three categories: screening, cognitive assessment, intervention. The survey included European professionals, experts in CRCI. The Delphi method was used: experts rated the clinical relevancy of recommendations on a 9-point Likert scale in three rounds. A recommendation was accepted if all votes were between 7 and 9. Recommendations not accepted in round 1 and round 2 were deleted, or modified and rated in round 3.ResultsEighteen professionals (psychologists, physicians, researchers) voted and accepted 15 recommendations. Experts recommended the systematic screening of CRCI, followed by a short objective cognitive assessment, if complaints screened. A comprehensive evaluation is recommended if CRCI persists 6 months post-treatment. Cognitive rehabilitation, physical activity, meditative-movement therapy, and multimodal intervention should be offered. Recommendations about frequency and duration of interventions, the professional to administer cognitive rehabilitation and the use of meditation and cognitive training without psychoeducation were not accepted.ConclusionsThis survey provides 15 recommendations to assist healthcare professionals in detecting, assessing and offering interventions for CRCI.Implications for cancer survivorsThese recommendations should be included in supportive care to help healthcare professionals to detect CRCI and propose the best available intervention for patients with cognitive complaints. Developing CRCI management in clinical settings would improve patients' quality of life. | |
dc.language.iso | EN | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject.en | Cancer | |
dc.subject.en | Cancer-related cognitive impairment | |
dc.subject.en | Cognitive rehabilitation | |
dc.subject.en | Delphi method | |
dc.subject.en | Non-pharmacological interventions | |
dc.subject.en | Screening | |
dc.title.en | Improve the management of cancer-related cognitive impairment in clinical settings: a European Delphi study | |
dc.title.alternative | J Cancer Surviv | en_US |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1007/s11764-023-01436-8 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
dc.identifier.pubmed | 37934312 | en_US |
bordeaux.journal | Journal of Cancer Survivorship | en_US |
bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.institution | INSERM | en_US |
bordeaux.team | PHARES_BPH | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
bordeaux.identifier.funderID | Institut National Du Cancer | en_US |
bordeaux.identifier.funderID | Unicancer | en_US |
hal.identifier | hal-04386956 | |
hal.version | 1 | |
hal.date.transferred | 2024-01-11T08:40:04Z | |
hal.popular | non | en_US |
hal.audience | Internationale | en_US |
hal.export | true | |
dc.rights.cc | Pas de Licence CC | en_US |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Cancer%20Survivorship&rft.date=2023-11-07&rft.eissn=1932-2267&rft.issn=1932-2267&rft.au=DUIVON,%20Mylene&LANGE,%20Marie&BINARELLI,%20Giulia&LEFEL,%20Johan&HARDY-LEGER,%20Isabelle&rft.genre=article |